Ophthalmic Plastic and Reconstructive Surgery最新文献_第10页

Nodular Fasciitis Resulting in a Nasolacrimal Duct Obstruction. 结节性筋膜炎导致鼻泪管阻塞

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-04-29 DOI: 10.1097/IOP.0000000000002661

Daniel A Rodriguez, Darius Bordbar, Lucy I Mudie, Debra J Shetlar, Michael T Yen

引用次数: 0

An Unusual Case of an Intradiploic Arachnoid Cyst of the Orbit. 眼眶内蛛网膜囊肿的罕见病例

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-05-17 DOI: 10.1097/IOP.0000000000002677

Santiago Ortiz-Perez, Francisco Zamorano-Martín, Ewa Maciag, Joaquim Enseñat

引用次数: 0

Magnetic Resonance Imaging of Idiopathic Orbital Myositis. 特发性眼眶肌炎的磁共振成像。

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-09-05 DOI: 10.1097/IOP.0000000000002640

Terence Ang, Jessica Y Tong, Sandy Patel, Thomas G Hardy, Alan McNab, Dinesh Selva

{"title":"Magnetic Resonance Imaging of Idiopathic Orbital Myositis.","authors":"Terence Ang, Jessica Y Tong, Sandy Patel, Thomas G Hardy, Alan McNab, Dinesh Selva","doi":"10.1097/IOP.0000000000002640","DOIUrl":"10.1097/IOP.0000000000002640","url":null,"abstract":"Purpose: To characterize the qualitative and quantitative features of idiopathic orbital myositis (IOM) on MRI.Methods: This was a multicenter retrospective study of patients with active IOM with MRI. Patients with incomplete clinical records, poor-quality or interval scans without active myositis, and specific orbital myositis (i.e., orbital myositis secondary to an identified condition) were excluded. An enlargement ratio was calculated by dividing the diameters of the affected extraocular muscle (EOM) by the contralateral unaffected EOM.Results: Twenty-four patients (mean age: 44.4 ± 17.8 years-old, male: 11) between 2011 and 2022 were included. One case (4.2%) was pediatric (17 years old), and 6 cases presented with recurrence. Active IOM was characterized by fusiform EOM enlargement, high T2 signal, and contrast enhancement. Average maximal EOM diameters ranged from 4.6 to 7.7 mm (enlargement ratio: 1.4-2.2). Eighteen (75%) patients had single EOM involvement, most commonly the medial rectus. Other ipsilateral structures affected included focal orbital fat (16/24, 66.7%) and lacrimal gland (8/24, 33.3%). Contralateral changes in the EOM and/or lacrimal gland were observed in 7 patients (29.2%). Patients presenting with recurrence were likely to develop ongoing recurrent episodes ( p = 0.003).Conclusions: Various radiological patterns of involvement described including EOM enlargement, contrast enhancement, abnormal signal, and involvement of other orbital structures are indicative of active IOM. IOM remains a heterogeneous spectrum of acute and chronic clinico-radiological presentations. Inflammation may involve other ipsilateral or contralateral orbital structures or may be bilateral despite presenting clinically as unilateral disease. Quantitative measurements may have utility in differentiating IOM from other causes of orbital myositis.","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erdheim-Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022. 眼睑和眼眶受累的 Erdheim-Chester 病：2014年至2022年一家机构的治疗模式回顾。

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-09-05 DOI: 10.1097/IOP.0000000000002619

Meghan Sharma, Shanlee M Stevens, Michelle M Maeng, Natalya Nagornaya, Rita G Bhatia, Sara T Wester

{"title":"Erdheim-Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022.","authors":"Meghan Sharma, Shanlee M Stevens, Michelle M Maeng, Natalya Nagornaya, Rita G Bhatia, Sara T Wester","doi":"10.1097/IOP.0000000000002619","DOIUrl":"10.1097/IOP.0000000000002619","url":null,"abstract":"Purpose: To review all cases of Erdheim-Chester disease (ECD) with orbital involvement treated at Bascom Palmer Eye Institute in Miami, Florida from 2014 to 2022 and compare presentations, treatment modalities, and outcomes.Methods: A retrospective chart review of all patients diagnosed with ECD who presented to Bascom Palmer Eye Institute from 2014 to 2022 was performed. Data collected included demographics, pretreatment history and ophthalmic examination, pathology report, treatment, subsequent examination, and relevant laboratory results. Histopathology, treatments, and outcomes were reviewed and compared between patients.Results: Four cases were included. Primary treatments included vemurafenib (n = 2), cobimetinib (n = 1), and prednisone (n = 1). All patients demonstrated improvement of ophthalmic symptoms. Vemurafenib was the only medical treatment that was tolerated well and resulted in significant improvement in proptosis despite some reported dry eye; all other medications were discontinued due to intolerable side effects.Conclusions: BRAF inhibitors such as vemurafenib have been used as novel therapy in the treatment of ECD. Vemurafenib demonstrated its utility in reducing proptosis in ECD patients at one ophthalmic institution. Vemurafenib may be a favorable treatment option for BRAF -positive ECD patients presenting with orbital disease.","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lacrimal Flatus. 泪腺扁平苔藓

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-09-05 DOI: 10.1097/IOP.0000000000002687

Md Shahid Alam

引用次数: 0

Invasive Squamous Cell Carcinoma Arising From a Cystic Brow Mass. 眉毛囊性肿块引发的浸润性鳞状细胞癌

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-03-21 DOI: 10.1097/IOP.0000000000002653

Chloe Y Li, Madison E Weiss, Allison V Coombs, Sun Yu, Michael Kazim

引用次数: 0

Atypical Periocular Lesions: Muir-Torre Syndrome. 非典型眼周病变：穆尔-托雷综合征

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-04-29 DOI: 10.1097/IOP.0000000000002660

Viet Chau, Nicholas DeLuca, Charissa Tan, Sohaib Fasih-Ahmad, Sander R Dubovy, Andrew J Rong

引用次数: 0

Severe Systemic Autoimmune Disease and Socket Necrosis. 严重的系统性自身免疫性疾病和眼窝坏死。

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-02-02 DOI: 10.1097/IOP.0000000000002613

Kaveh Vahdani, Geoffrey E Rose

引用次数: 0

Enlarging Orbital Rim Mass Due to Old Pencil Injury. 铅笔旧伤导致眼眶边缘肿块增大。

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-05-22 DOI: 10.1097/IOP.0000000000002658

Nahrain Putris Schumaier, Lauren DeMaria Mileo, Robert Folberg, Dianne M Schlachter

引用次数: 0

The Dysmorphic Concern Questionnaire: Is It Possible to Predict a Satisfactory Result After Cosmetic Eyelid Surgery? 畸形关注问卷：能否预测眼睑整容手术后的满意结果？

IF 1.2 4区医学

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2024-09-01 Epub Date: 2024-03-21 DOI: 10.1097/IOP.0000000000002657

Martin H Devoto, Andrés I Díaz Ricci, Cecilia Gasparini

{"title":"The Dysmorphic Concern Questionnaire: Is It Possible to Predict a Satisfactory Result After Cosmetic Eyelid Surgery?","authors":"Martin H Devoto, Andrés I Díaz Ricci, Cecilia Gasparini","doi":"10.1097/IOP.0000000000002657","DOIUrl":"10.1097/IOP.0000000000002657","url":null,"abstract":"Purpose: As oculofacial surgeons performing esthetic surgery, the most valuable result is a satisfied patient. It can be extremely frustrating to have an unhappy patient with, what we believe is, a satisfactory result. Therefore, the ability to predict satisfaction is of extreme importance. We studied our cosmetic eyelid surgery patients to try to find factors that can predict satisfaction.Methods: We retrospectively studied 454 consecutive patients, who underwent any combination of 7 cosmetic surgical procedures. Patients answered the Dysmorphic Concern Questionnaire (DCQ) before surgery. We studied age, gender, type and number of procedures performed, DCQ score, presence of complications, and history of previous fillers. At the 3-month follow-up visit, patients were given an outcome report survey to graduate their surgical results on a scale from 1 to 5. Results were evaluated using a model of binary logistic regression in which the outcome variable was divided into 2 groups.Results: Three hundred eighty-six patients (85%) were female and the median age was 54.8 years old. The median for the number of procedures was 2 (range, 1-5). Two hundred two of the 454 patients (44.5%) had a history of fillers. Twenty-five patients had complications. DCQ score was significantly lower in the satisfied group (median score, 3) versus the unsatisfied group (median, 6), p = 0.007. In the multiple binary logistical model, the variables age, male gender, DCQ, presence of complications, and upper eyelid blepharoplasty resulted as significant.Conclusions: We found a significant positive association with upper lid blepharoplasty and a negative association with increasing age, male gender, occurrence of complications, and DCQ score, as predictors of patient satisfaction. We routinely administer the DCQ to all cosmetic patients: It is a brief, sensitive, and specific screening instrument for body dysmorphic disorder.","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140294118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0